Amoy Diagnostics
Xiamen · Founded 2008
About Amoy Diagnostics
Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene testing panels, NGS panels, and NGS analytical systems.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $26.3M
- Funding stage: IPO
- Last round: Series B (Mar 2015)
- Ticker: szse:300685
- Website: amoydx.com
- Phone: +86 592 680 6835
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/amoy-diagnostics-3126762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.